000			01960nam a22002417a 4500
003			ISI Library, Kolkata
005			20240806151230.0
008			240806b |||||||| |||| 00| 0 eng d
020			_a9241207604
040			_aISI Library _bEnglish
082	0	4	_a100 SD;610.621 _bWHO.TR.760
110	1		_aWHO Expert Committee on Biological Standardization
245	1	0	_aWHO Expert Committee on Biological Standardization : _bthirty-seventh report, meeting held in Geneva from 1 to 8 December 1986
260			_aGeneva : _bWorld Health Organization, _c1987
300			_a203 Pages; _c20 cm.
490	0		_aWorld Health Organization technical report series ; no. 760
505	0		_aGeneral -- Substances: Antibiotics -- Antibodies -- Blood products and related substances -- Endocrinological and related substances -- Miscellaneous -- requirements for biological substances -- Annaxes
520			_aAnnounces changes in the status or development of international standards for 35 biologicals, classified as antibiotics, antibodies, antigens, blood products and related substances, endocrinological and related substances, and a miscellaneous group of substances. The report also provides detailed information on requirements for the manufacturing, testing, and quality control of selected vaccines, including hepatitis B vaccines made by recombinant DNA techniques in yeast, live mumps vaccine, and inactivated rabies vaccine produced in continuous cell lines. Of particular practical interest is an extensive report on a WHO meeting concerned with the use of recombinant DNA techniques to produce hepatitis B vaccines. The report also includes amendments to previous requirements for oral poliomyelitis vaccine and for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines.
650		4	_aBiological Products
650		4	_aPharmacology, Toxicology and Clinical Technology
710	1		_aWorld Health Organization
942			_2ddc _cRP
999			_c435595 _d435595